I am interested in iPSC-derived immune cells, specifically NK and γδ T cells, and their cytotoxic effects on various tumors. Additionally, I am exploring the interactions between brain tumor cells and the cells within their microenvironment and how these interactions influence tumor progression and chemoresistance. I have expertise in techniques such as flow cytometry, qPCR, ELISA, and protein analysis, which I apply in the context of cell-based cancer therapies. I have published my research in peer-reviewed journals and presented my findings at national conferences.